Evidence map›Paper›PMID 41368594›Full record

ArticleNanoscale advances2026

Flow-reactor synthesis of octahedral Pt-Ni nanoparticles modified with Au and their evaluation as oxygen reduction reaction catalysts.

Tomoyuki Nagai, Akira Kuwaki, Kensaku Kodama

Abstract read
In one paragraph

Article in Nanoscale advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tomoyuki NagaiToyota Central R&D Labs. Inc. 41-1 Yokomichi Nagakute Aichi 480-1192 Japan ngtmyk@mosk.tytlabs.co.jp.ORCID https://orcid.org/0000-0003-4976-7301
Akira KuwakiToyota Central R&D Labs. Inc. 41-1 Yokomichi Nagakute Aichi 480-1192 Japan ngtmyk@mosk.tytlabs.co.jp.
Kensaku KodamaToyota Central R&D Labs. Inc. 41-1 Yokomichi Nagakute Aichi 480-1192 Japan ngtmyk@mosk.tytlabs.co.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing oxygen reduction reaction (ORR) catalysts with both high catalytic activity and durability is essential for the commercialization of polymer electrolyte fuel cells (PEFCs). One promising strategy to simultaneously enhance the catalytic activity and durability of Pt-based catalysts is surface modification with Au, which has led to substantial durability improvements in various catalysts such as bulk electrodes, nanowires, and core-shell structures. In this study, octahedral Pt-Ni nanoparticles (oct-Pt-Ni NPs), which are known to exhibit exceptionally high ORR activity, were synthesized and modified with Au using a continuous flow reactor to investigate the effects of Au modification on catalytic activity and durability. The flow synthesis enabled uniform Au deposition on individual nanoparticles owing to the rapid mixing and homogeneous contact between the Au precursor and Pt-Ni nanoparticles. Electrochemical measurements revealed that Au modification enhanced the specific activity (SA) by up to 1.5 times, while the mass activity (MA) remained nearly unchanged owing to the decrease in electrochemical surface area of Pt. The activity enhancement suggests that Au atoms promote the catalytic activity of the neighboring Au-free Pt-Ni sites as previously reported. In contrast, the MA of Au-modified oct-Pt-Ni NPs rapidly decreased within several hundred potential cycles along with the decrease in the SA, indicating that Au atoms on the Pt-Ni nanoparticles could not effectively suppress Ni leaching or morphological transformation. These results suggest that the beneficial effect of Au modification on durability is limited for shape-sensitive catalysts with numerous vulnerable edges and corners such as oct-Pt-Ni nanoparticles, unlike the spherical or nanowire catalysts with smooth or well-faceted surfaces.

Identifiers

PMID41368594
PMCPMC12683288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.